Icatibant 00093-3066-34
- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 15, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA210118
Need to source Icatibant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Icatibant Acetate | 10 mg/mL |
Drug Class
Bradykinin B2 Receptor Antagonist [EPC]Bradykinin B2 Receptor Antagonists [MoA]
Selected Package
00093-3066-34Selected1 SYRINGE in 1 CARTON (0093-3066-34) / 3 mL in 1 SYRINGE
Other packages for this product(1)
3 CARTON in 1 BOX (0093-3066-93) / 1 SYRINGE in 1 CARTON (0093-3066-19) / 3 mL in 1 SYRINGE